手机版 English 帮助中心
外文文献知网节
文献信息节点
基本信息 摘要 关键词 核心评价 相关文献
Journal | [J] 临床医学研究 Volume 5, Issue 3. 2023.
老年房颤合并高血压患者强化降压治疗的研究进展
作者 : 姜 博, 贺 利平
DOI: 10.12361/2705-0939-05-03-127102
全部来源
获取全文
摘要 / Abstract
心房颤动（Atrial fibrillation，AF）和高血压（Hypertension）是两种常见的心血管疾病，两种疾病患病率高，且经 常出现在老年患者中。二者相互共存，互相影响，其中高血压是引起心房颤动的独立危险因素之一，占其发病因素中的14% ，与此同时心房颤动的患者多数合并有高血压，数据高达53%。由于两种疾病严重影响老年患者生存周期，近几年国内外指 南表明更为严格的降压目标实施后对于老年患者的生存受益良多。故笔者对老年心房颤动合并高血压患者强化降压治疗效果 的研究进展做一综述加以总结。
关键词 / Keywords
强化降压；高血压；心房颤动
Related articles / 相关文献
相似文献
作者发文
机构发文
关键词分析
相似文献（说明：与本文内容较接近的文献）
  • [1]Kallistratos M S, Poulimenos L E, Manolis A J. Atrial
  • fibrillation and arterial hypertension [J]. Pharmacol Res, 2018, 128: 322-326. [2]Emdin C A, Anderson S G, Salimi-Khorshidi G, et al. Usual blood pressure, atrial fibrillation and vascular risk:
  • evidence from 4.3 million adults [J]. Int J Epidemiol, 2017, 46(1): 162-172. [3]Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a
  • systematic analysis for the Global Burden of Disease Study
  • 2017 [J]. Lancet, 2019, 394(10204): 1145-1158. [4]Fuster V, Rydén L E, Cannom D S, et al. ACC/AHA/ESC 2006 Guidelines for the Management of
  • Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology
  • Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm
  • Society [J]. Circulation, 2006, 114(7): e257-354. [5]Verdecchia P, Angeli F, Reboldi G. Hypertension and
  • Atrial Fibrillation: Doubts and Certainties From Basic and
  • Clinical Studies [J]. Circ Res, 2018, 122(2): 352-368. [6]Whelton P K, Carey R M, Aronow W S, et al. 2017
  • ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA
  • /PCNA Guideline for the Prevention, Detection, Evaluation, and
  • Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [J]. Hypertension, 2018, 71(6): e13-e115. [7]Wright J T, Jr., Williamson J D, Whelton P K, et al. A
  • Randomized Trial of Intensive versus Standard Blood-Pressure Control [J]. N Engl J Med, 2015, 373(22): 2103-2116. [8]Soliman E Z, Rahman A F, Zhang Z M, et al. Effect of
  • Intensive Blood Pressure Lowering on the Risk of Atrial
  • Fibrillation [J]. Hypertension, 2020, 75(6): 1491-1496. [9]Sobieraj P, Nilsson P M, Kahan T. Heart Failure Events
  • in a Clinical Trial on Arterial Hypertension: New Insights Into
  • the SPRINT Trial [J]. Hypertension, 2021, 78(5): 1241-1247. [10]Parcha V, Patel N, Kalra R, et al. Incidence and
  • Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial [J]. Hypertension, 2020, 75(6): 1483-1490. [11]Zhang W, Zhang S, Deng Y, et al. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension [J]. N Engl J Med, 2021, 385(14): 1268-1279. [12]Pinho-Gomes A C, Azevedo L, Copland E, et al. Blood
  • pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual
  • participant data meta-analysis [J]. PLoS Med, 2021, 18(6): e1003599. [13]Verdecchia P, Staessen J A, Angeli F, et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial [J]. Lancet, 2009, 374(9689): 525-533. [14]Thomas M C, Dublin S, Kaplan R C, et al. Blood
  • pressure control and risk of incident atrial fibrillation [J]. Am J
  • Hypertens, 2008, 21(10): 1111-1116. [15]Heijman J, Voigt N, Nattel S, et al. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression [J]. Circ Res, 2014, 114(9): 1483- 1499.[16]Qiu D, Peng L, Ghista D N, et al. Left Atrial
  • Remodeling Mechanisms Associated with Atrial Fibrillation [J]. Cardiovasc Eng Technol, 2021, 12(3): 361-372. [17]Nattel S, Burstein B, Dobrev D. Atrial remodeling and
  • atrial fibrillation: mechanisms and implications [J]. Circ Arrhythm Electrophysiol, 2008, 1(1): 62-73. [18]Huang Z, Zheng Z, Wu B, et al. Predictive value of P wave terminal force in lead V1 for atrial fibrillation: A meta- analysis [J]. Ann Noninvasive Electrocardiol, 2020, 25(4): e12739. [19]Kamel H, Hunter M, Moon Y P, et al. Electrocardiographic Left Atrial Abnormality and Risk of
  • Stroke: Northern Manhattan Study [J]. Stroke, 2015, 46(11): 3208-3212.
  • [20]Kamel H, Rahman A F, O'Neal W T, et al. Effect of
  • intensive blood pressure lowering on left atrial remodeling in
  • the SPRINT [J]. Hypertens Res, 2021, 44(10): 1326-1331. [21]Chen L Y, Bigger J T, Hickey K T, et al. Effect of
  • Intensive Blood Pressure Lowering on Incident Atrial
  • Fibrillation and P-Wave Indices in the ACCORD Blood
  • Pressure Trial [J]. Am J Hypertens, 2016, 29(11): 1276-1282. [22]Cuspidi C, Tadic M, Grassi G, et al. Treatment of
  • hypertension: The ESH/ESC guidelines recommendations [J]. Pharmacol Res, 2018, 128: 315-321. [23]Hindricks G, Potpara T, Dagres N, et al. 2020 ESC
  • Guidelines for the diagnosis and management of atrial
  • fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task
  • Force for the diagnosis and management of atrial fibrillation of
  • the European Society of Cardiology (ESC) Developed with the
  • special contribution of the European Heart Rhythm Association
  • (EHRA) of the ESC [J]. Eur Heart J, 2021, 42(5): 373-498. [24]January C T, Wann L S, Calkins H, et al. 2019
  • AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS
  • Guideline for the Management of Patients With Atrial
  • Fibrillation: A Report of the American College of
  • Cardiology/American Heart Association Task Force on Clinical
  • Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons [J]. Circulation, 2019, 140(2): e125-e151. [25]Chatap G, Giraud K, Vincent J P. Atrial fibrillation in
  • the elderly: facts and management [J]. Drugs Aging, 2002, 19(11): 819-846.
《中国学术期刊(光盘版)》电子杂志社有限公司 KDN平台基础技术由KBASE 11.0提供
© 2014-2018中国知网(CNKI) 京公网安备11010802020460号 经营性网站备案信息 互联网出版许可证 新出网证(京)字271号 京ICP证040431号